Resources Contact Us Home
Recombinant thrombin receptor and related pharmaceuticals

Image Number 9 for United States Patent #7119182.

The DNA encoding the cell surface receptor for thrombin has been cloned and sequenced. The availability of this DNA permits the recombinant production of thrombin receptor which can be produced at cell surfaces and is useful in assay systems both for the detection of thrombin and for the evaluation of candidate thrombin agonists and antagonists. Further, the elucidation of the structure of the thrombin receptor permits the design of agonist and antagonist compounds which are useful diagnostically and therapeutically. The availability of the thrombin receptor also permits production of antibodies specifically immunoreactive with the receptor per se or with specific regions thereof which are also useful diagnostically or therapeutically.

  Recently Added Patents
Mobile terminal and method for changing page thereof
Visual indicator of online backup
Electronic hand-held device
Synthesized interoperable communications
System and method for managing content on a network interface
Decentralized processing network
  Randomly Featured Patents
Parallel robotic gripper
Computer aided ligand-based and receptor-based drug design utilizing molecular shape and electrostatic complementarity
Survival suit
Optimized particulate surface treatment concentration for electrostatographic images produced in an electrostatographic engine that includes a compliant intermediate transfer member
Injection molding apparatus having an elongated nozzle incorporating multiple nozzle bodies in tandem
Differential amplifier with enhanced slew rate
Method for programming/parallel programming of onboard flash memory by multiple access bus
Method and system for distributed RAID implementation
Universal computer input event translator
Methods of reducing plasma-induced damage for advanced plasma CVD dielectrics